View ValuationMothercare 향후 성장Future 기준 점검 0/6Mothercare 의 수익은 연간 72.5% 감소할 것으로 예상되는 반면, 연간 수익은 2.7% 로 증가할 것으로 예상됩니다. EPS는 연간 72.9% 만큼 쇠퇴할 것으로 예상됩니다.핵심 정보-72.5%이익 성장률-72.94%EPS 성장률Specialty Retail 이익 성장12.5%매출 성장률2.7%향후 자기자본이익률n/a애널리스트 커버리지Low마지막 업데이트13 Apr 2026최근 향후 성장 업데이트Major Estimate Revision • Dec 30Consensus revenue estimates decrease by 42%The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from UK£45.9m to UK£26.8m. EPS estimate unchanged from -UK£0.0025 per share at last update. Specialty Retail industry in the United Kingdom expected to see average net income growth of 37% next year. Consensus price target down from UK£0.098 to UK£0.072. Share price rose 15% to UK£0.025 over the past week.Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.Price Target Changed • Apr 19Price target increased by 15% to UK£0.15Up from UK£0.13, the current price target is provided by 1 analyst. New target price is 180% above last closing price of UK£0.053. Stock is down 39% over the past year. The company is forecast to post earnings per share of UK£0.005 next year compared to a net loss per share of UK£0.00018 last year.Price Target Changed • Mar 12Price target decreased by 15% to UK£0.14Down from UK£0.17, the current price target is an average from 2 analysts. New target price is 63% above last closing price of UK£0.086. Stock is down 30% over the past year. The company is forecast to post earnings per share of UK£0.0015 for next year compared to UK£0.021 last year.모든 업데이트 보기Recent updatesNew Risk • Apr 14New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 91% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 91% per year for the foreseeable future. Market cap is less than US$10m (UK£6.29m market cap, or US$8.52m).New Risk • Mar 23New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£7.02m (US$9.43m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 95% per year for the foreseeable future. Market cap is less than US$10m (UK£7.02m market cap, or US$9.43m).New Risk • Mar 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 95% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£11.0m market cap, or US$14.8m).분석 기사 • Jan 15Some Confidence Is Lacking In Mothercare plc's (LON:MTC) P/SIt's not a stretch to say that Mothercare plc's ( LON:MTC ) price-to-sales (or "P/S") ratio of 0.4x seems quite...New Risk • Jan 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 85% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£11.3m market cap, or US$15.2m).Major Estimate Revision • Dec 30Consensus revenue estimates decrease by 42%The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from UK£45.9m to UK£26.8m. EPS estimate unchanged from -UK£0.0025 per share at last update. Specialty Retail industry in the United Kingdom expected to see average net income growth of 37% next year. Consensus price target down from UK£0.098 to UK£0.072. Share price rose 15% to UK£0.025 over the past week.Reported Earnings • Dec 25First half 2026 earnings released: UK£0.003 loss per share (vs UK£0.003 loss in 1H 2025)First half 2026 results: UK£0.003 loss per share (in line with 1H 2025). Revenue: UK£11.6m (down 45% from 1H 2025). Net loss: UK£1.70m (loss narrowed 5.6% from 1H 2025). Revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings.공시 • Sep 26Mothercare plc, Annual General Meeting, Nov 12, 2025Mothercare plc, Annual General Meeting, Nov 12, 2025. Location: westside 1, london road, hp3 9td, hemel hempstead United KingdomReported Earnings • Sep 25Full year 2025 earnings released: EPS: UK£0.011 (vs UK£0.006 in FY 2024)Full year 2025 results: EPS: UK£0.011 (up from UK£0.006 in FY 2024). Revenue: UK£38.9m (down 31% from FY 2024). Net income: UK£6.20m (up 88% from FY 2024). Profit margin: 16% (up from 5.9% in FY 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings.New Risk • Jun 25New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 16% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (UK£16.2m market cap, or US$22.0m).New Risk • Jun 20New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (UK£14.7m market cap, or US$19.8m).New Risk • May 12New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 16% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£12.6m market cap, or US$16.6m).분석 기사 • May 09Take Care Before Jumping Onto Mothercare plc (LON:MTC) Even Though It's 26% CheaperUnfortunately for some shareholders, the Mothercare plc ( LON:MTC ) share price has dived 26% in the last thirty days...분석 기사 • Mar 06Not Many Are Piling Into Mothercare plc (LON:MTC) Stock Yet As It Plummets 28%The Mothercare plc ( LON:MTC ) share price has fared very poorly over the last month, falling by a substantial 28%. For...분석 기사 • Jan 12Market Might Still Lack Some Conviction On Mothercare plc (LON:MTC) Even After 27% Share Price BoostMothercare plc ( LON:MTC ) shares have had a really impressive month, gaining 27% after a shaky period beforehand. Not...Recent Insider Transactions • Dec 20Non-Executive Chairman recently bought UK£100k worth of stockOn the 18th of December, Clive Whiley bought around 4m shares on-market at roughly UK£0.025 per share. This transaction increased Clive's direct individual holding by 1x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Clive's only on-market trade for the last 12 months.공시 • Nov 22Mothercare plc Announces Resignation of Mark Newton from the BoardMothercare plc announced upon Clive Whiley’s appointment as Chairman, Mark Newton Jones agreed to return to the board as a non-executive director to lend his support to the Transformation Plan and subsequently the actions necessary to combat the impact of the pandemic and the Ukraine conflict on the business. Accordingly, following creation of the new India joint venture and coterminous refinancing, Mark had indicated his intention to stand down from the board at its AGM and has now resigned as a director.공시 • Oct 22Mothercare plc, Annual General Meeting, Nov 19, 2024Mothercare plc, Annual General Meeting, Nov 19, 2024. Location: westside 1, london road, hp3 9td, hemel hempstead United Kingdom분석 기사 • Oct 20Mothercare plc's (LON:MTC) Shares Climb 49% But Its Business Is Yet to Catch UpMothercare plc ( LON:MTC ) shares have had a really impressive month, gaining 49% after a shaky period beforehand...Reported Earnings • Oct 19First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.001 in 1H 2023)First half 2024 results: EPS: UK£0.003 (up from UK£0.001 in 1H 2023). Revenue: UK£29.0m (down 25% from 1H 2023). Net income: UK£1.70m (up 325% from 1H 2023). Profit margin: 5.9% (up from 1.0% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is expected to decline by 5.6% p.a. on average during the next 4 years, while revenues in the Specialty Retail industry in the United Kingdom are expected to grow by 5.4%.Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.New Risk • Sep 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 9.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Share price has been highly volatile over the past 3 months (9.7% average weekly change). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£18.9m market cap, or US$25.2m).분석 기사 • Jul 04Is Mothercare plc (LON:MTC) Potentially Undervalued?Mothercare plc ( LON:MTC ), might not be a large cap stock, but it saw a decent share price growth of 13% on the AIM...New Risk • Jun 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£26.2m market cap, or US$33.4m).Price Target Changed • Apr 19Price target increased by 15% to UK£0.15Up from UK£0.13, the current price target is provided by 1 analyst. New target price is 180% above last closing price of UK£0.053. Stock is down 39% over the past year. The company is forecast to post earnings per share of UK£0.005 next year compared to a net loss per share of UK£0.00018 last year.분석 기사 • Apr 18Mothercare plc (LON:MTC) Shares May Have Slumped 25% But Getting In Cheap Is Still UnlikelyMothercare plc ( LON:MTC ) shareholders that were waiting for something to happen have been dealt a blow with a 25...분석 기사 • Jan 03Is Now The Time To Look At Buying Mothercare plc (LON:MTC)?Mothercare plc ( LON:MTC ), is not the largest company out there, but it led the AIM gainers with a relatively large...Reported Earnings • Nov 28First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.001 in 1H 2023)First half 2024 results: EPS: UK£0.003 (up from UK£0.001 in 1H 2023). Revenue: UK£29.0m (down 25% from 1H 2023). Net income: UK£1.70m (up 325% from 1H 2023). Profit margin: 5.9% (up from 1.0% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.New Risk • Nov 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.3x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (10.0% average weekly change). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£29.9m market cap, or US$37.7m).분석 기사 • Nov 04Mothercare plc (LON:MTC) Investors Are Less Pessimistic Than ExpectedWith a median price-to-sales (or "P/S") ratio of close to 0.3x in the Specialty Retail industry in the United Kingdom...공시 • Sep 27Mothercare plc, Annual General Meeting, Oct 23, 2023Mothercare plc, Annual General Meeting, Oct 23, 2023, at 10:00 Coordinated Universal Time. Location: Westside 1, London Road Hemel Hemsptead United Kingdom Agenda: To receive the Company's annual accounts, together with the directors' report, the strategic report, the directors' remuneration report and the auditors' report for the 52 weeks ended 25 March 2023; to approve the directors' remuneration report for the 52 weeks ended 25 March 2023; to re-elect Clive Whiley as a director of the Company; to re-elect Andrew Cook as a director of the Company; to re-elect Gillian Kent as a director of the Company; to re-elect Mark Newton-Jones as a director of the Company; to re-elect Brian Small as a director of the Company and to consider other business matters.Reported Earnings • Sep 24Full year 2023 earnings released: EPS: UK£0 (vs UK£0.021 in FY 2022)Full year 2023 results: EPS: UK£0 (down from UK£0.021 in FY 2022). Revenue: UK£73.1m (down 11% from FY 2022). Net loss: UK£100.0k (down 101% from profit in FY 2022). Revenue is forecast to stay flat during the next 3 years compared to a 5.9% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.분석 기사 • Aug 18We Like Mothercare's (LON:MTC) Returns And Here's How They're TrendingTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...New Risk • Jul 25New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings are forecast to decline by an average of 34% per year for the foreseeable future. Minor Risks High level of debt (883% net debt to equity). Market cap is less than US$100m (UK£34.2m market cap, or US$44.0m).분석 기사 • Jun 11When Should You Buy Mothercare plc (LON:MTC)?Mothercare plc ( LON:MTC ), might not be a large cap stock, but it saw significant share price movement during recent...공시 • Jun 09+ 1 more updateMothercare plc Daniel Le Vesconte to Step Down from His Role as Director of the BoardMothercare plc announces that Daniel Le Vesconte has stepped down from his role as Chief Executive Officer ("CEO") and as a Director of the Board with immediate effect. Clive Whiley, the Company's Chairman and Andrew Cook, the CFO, will revert to leading the Operating Board, as was the case for the previous three years, until the process to find a replacement CEO is completed.분석 기사 • Mar 13Mothercare (LON:MTC) Is Very Good At Capital AllocationWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...Price Target Changed • Mar 12Price target decreased by 15% to UK£0.14Down from UK£0.17, the current price target is an average from 2 analysts. New target price is 63% above last closing price of UK£0.086. Stock is down 30% over the past year. The company is forecast to post earnings per share of UK£0.0015 for next year compared to UK£0.021 last year.Board Change • Mar 12Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non Executive Director Brian Small was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 30First half 2021 earnings released: UK£0.038 loss per shareThe company reported a poor first half result with weaker earnings, revenues and control over expenses. First half 2021 results: Revenue: UK£44.4m (down 56% from 1H 2020). Net loss: UK£14.1m (down 352% from profit in 1H 2020). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings.Reported Earnings • Sep 28Full year earnings released - UK£0.02 loss per shareOver the last 12 months the company has reported total losses of UK£7.20m, with losses narrowing by 67% from the prior year. Total revenue was UK£164.7m over the last 12 months, down 18% from the prior year.이익 및 매출 성장 예측AIM:MTC - 애널리스트 향후 추정치 및 과거 재무 데이터 (GBP Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수3/31/202832-2-1113/31/202730-31213/31/202630-3-2N/A19/27/2025306-3-2N/A6/27/2025346-3-2N/A3/29/2025396-3-1N/A12/29/202444302N/A9/28/202448035N/A6/28/202452235N/A3/30/202456335N/A12/30/202360213N/A9/23/202364102N/A6/23/202368113N/A3/25/202373024N/A12/25/202276446N/A9/24/202279958N/A6/24/2022811158N/A3/26/2022831258N/A12/26/2021834N/AN/AN/A9/25/202183-5-2-1N/A6/25/202184-13-2-2N/A3/27/202186-21-3-3N/A12/27/202096-24N/AN/AN/A10/10/2020107-2766N/A7/10/2020136-1823N/A3/28/2020165-8-11N/A12/28/201998-220N/A10/12/20193255-1N/A7/12/2019116-8N/A0N/A3/30/2019200-21N/A1N/A10/6/2018511-99N/A8N/A7/6/2018546-96N/A5N/A3/24/2018581-93N/A1N/A12/24/2017657-41N/A4N/A10/7/2017659-7N/A8N/A7/7/20176631N/A12N/A3/25/20176678N/A15N/A12/25/20166745N/A12N/A10/8/20166802N/A9N/A7/8/20166814N/A15N/A3/26/20166826N/A22N/A12/26/2015687-4N/A16N/A10/10/2015691-15N/A10N/A7/10/2015703-15N/A4N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: MTC 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -72.5%).수익 vs 시장: MTC 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -72.5%).고성장 수익: MTC 의 수익은 향후 3년간 감소할 것으로 예상됩니다.수익 대 시장: MTC 의 수익(연간 2.7%)이 UK 시장(연간 4.7%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: MTC 의 수익(연간 2.7%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: MTC의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.성장 기업 찾아보기7D1Y7D1Y7D1YRetail 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/07 22:44종가2026/07/07 00:00수익2025/09/27연간 수익2025/03/29데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Mothercare plc는 12명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Robert ChantryBerenbergSanjay VidyarthiCanaccord GenuityNigel ParsonCavendish9명의 분석가 더 보기
Major Estimate Revision • Dec 30Consensus revenue estimates decrease by 42%The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from UK£45.9m to UK£26.8m. EPS estimate unchanged from -UK£0.0025 per share at last update. Specialty Retail industry in the United Kingdom expected to see average net income growth of 37% next year. Consensus price target down from UK£0.098 to UK£0.072. Share price rose 15% to UK£0.025 over the past week.
Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.
Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.
Price Target Changed • Apr 19Price target increased by 15% to UK£0.15Up from UK£0.13, the current price target is provided by 1 analyst. New target price is 180% above last closing price of UK£0.053. Stock is down 39% over the past year. The company is forecast to post earnings per share of UK£0.005 next year compared to a net loss per share of UK£0.00018 last year.
Price Target Changed • Mar 12Price target decreased by 15% to UK£0.14Down from UK£0.17, the current price target is an average from 2 analysts. New target price is 63% above last closing price of UK£0.086. Stock is down 30% over the past year. The company is forecast to post earnings per share of UK£0.0015 for next year compared to UK£0.021 last year.
New Risk • Apr 14New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 91% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 91% per year for the foreseeable future. Market cap is less than US$10m (UK£6.29m market cap, or US$8.52m).
New Risk • Mar 23New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: UK£7.02m (US$9.43m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 95% per year for the foreseeable future. Market cap is less than US$10m (UK£7.02m market cap, or US$9.43m).
New Risk • Mar 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 95% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£11.0m market cap, or US$14.8m).
분석 기사 • Jan 15Some Confidence Is Lacking In Mothercare plc's (LON:MTC) P/SIt's not a stretch to say that Mothercare plc's ( LON:MTC ) price-to-sales (or "P/S") ratio of 0.4x seems quite...
New Risk • Jan 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 85% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£11.3m market cap, or US$15.2m).
Major Estimate Revision • Dec 30Consensus revenue estimates decrease by 42%The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from UK£45.9m to UK£26.8m. EPS estimate unchanged from -UK£0.0025 per share at last update. Specialty Retail industry in the United Kingdom expected to see average net income growth of 37% next year. Consensus price target down from UK£0.098 to UK£0.072. Share price rose 15% to UK£0.025 over the past week.
Reported Earnings • Dec 25First half 2026 earnings released: UK£0.003 loss per share (vs UK£0.003 loss in 1H 2025)First half 2026 results: UK£0.003 loss per share (in line with 1H 2025). Revenue: UK£11.6m (down 45% from 1H 2025). Net loss: UK£1.70m (loss narrowed 5.6% from 1H 2025). Revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings.
공시 • Sep 26Mothercare plc, Annual General Meeting, Nov 12, 2025Mothercare plc, Annual General Meeting, Nov 12, 2025. Location: westside 1, london road, hp3 9td, hemel hempstead United Kingdom
Reported Earnings • Sep 25Full year 2025 earnings released: EPS: UK£0.011 (vs UK£0.006 in FY 2024)Full year 2025 results: EPS: UK£0.011 (up from UK£0.006 in FY 2024). Revenue: UK£38.9m (down 31% from FY 2024). Net income: UK£6.20m (up 88% from FY 2024). Profit margin: 16% (up from 5.9% in FY 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings.
New Risk • Jun 25New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 16% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (UK£16.2m market cap, or US$22.0m).
New Risk • Jun 20New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (UK£14.7m market cap, or US$19.8m).
New Risk • May 12New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 16% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-UK£29m). Earnings are forecast to decline by an average of 16% per year for the foreseeable future. Minor Risk Market cap is less than US$100m (UK£12.6m market cap, or US$16.6m).
분석 기사 • May 09Take Care Before Jumping Onto Mothercare plc (LON:MTC) Even Though It's 26% CheaperUnfortunately for some shareholders, the Mothercare plc ( LON:MTC ) share price has dived 26% in the last thirty days...
분석 기사 • Mar 06Not Many Are Piling Into Mothercare plc (LON:MTC) Stock Yet As It Plummets 28%The Mothercare plc ( LON:MTC ) share price has fared very poorly over the last month, falling by a substantial 28%. For...
분석 기사 • Jan 12Market Might Still Lack Some Conviction On Mothercare plc (LON:MTC) Even After 27% Share Price BoostMothercare plc ( LON:MTC ) shares have had a really impressive month, gaining 27% after a shaky period beforehand. Not...
Recent Insider Transactions • Dec 20Non-Executive Chairman recently bought UK£100k worth of stockOn the 18th of December, Clive Whiley bought around 4m shares on-market at roughly UK£0.025 per share. This transaction increased Clive's direct individual holding by 1x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Clive's only on-market trade for the last 12 months.
공시 • Nov 22Mothercare plc Announces Resignation of Mark Newton from the BoardMothercare plc announced upon Clive Whiley’s appointment as Chairman, Mark Newton Jones agreed to return to the board as a non-executive director to lend his support to the Transformation Plan and subsequently the actions necessary to combat the impact of the pandemic and the Ukraine conflict on the business. Accordingly, following creation of the new India joint venture and coterminous refinancing, Mark had indicated his intention to stand down from the board at its AGM and has now resigned as a director.
공시 • Oct 22Mothercare plc, Annual General Meeting, Nov 19, 2024Mothercare plc, Annual General Meeting, Nov 19, 2024. Location: westside 1, london road, hp3 9td, hemel hempstead United Kingdom
분석 기사 • Oct 20Mothercare plc's (LON:MTC) Shares Climb 49% But Its Business Is Yet to Catch UpMothercare plc ( LON:MTC ) shares have had a really impressive month, gaining 49% after a shaky period beforehand...
Reported Earnings • Oct 19First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.001 in 1H 2023)First half 2024 results: EPS: UK£0.003 (up from UK£0.001 in 1H 2023). Revenue: UK£29.0m (down 25% from 1H 2023). Net income: UK£1.70m (up 325% from 1H 2023). Profit margin: 5.9% (up from 1.0% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is expected to decline by 5.6% p.a. on average during the next 4 years, while revenues in the Specialty Retail industry in the United Kingdom are expected to grow by 5.4%.
Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.
Price Target Changed • Oct 18Price target decreased by 17% to UK£0.11Down from UK£0.13, the current price target is an average from 2 analysts. New target price is 115% above last closing price of UK£0.05. Stock is up 29% over the past year. The company is forecast to post earnings per share of UK£0.0049 next year compared to a net loss per share of UK£0.00018 last year.
New Risk • Sep 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 9.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Share price has been highly volatile over the past 3 months (9.7% average weekly change). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£18.9m market cap, or US$25.2m).
분석 기사 • Jul 04Is Mothercare plc (LON:MTC) Potentially Undervalued?Mothercare plc ( LON:MTC ), might not be a large cap stock, but it saw a decent share price growth of 13% on the AIM...
New Risk • Jun 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£26.2m market cap, or US$33.4m).
Price Target Changed • Apr 19Price target increased by 15% to UK£0.15Up from UK£0.13, the current price target is provided by 1 analyst. New target price is 180% above last closing price of UK£0.053. Stock is down 39% over the past year. The company is forecast to post earnings per share of UK£0.005 next year compared to a net loss per share of UK£0.00018 last year.
분석 기사 • Apr 18Mothercare plc (LON:MTC) Shares May Have Slumped 25% But Getting In Cheap Is Still UnlikelyMothercare plc ( LON:MTC ) shareholders that were waiting for something to happen have been dealt a blow with a 25...
분석 기사 • Jan 03Is Now The Time To Look At Buying Mothercare plc (LON:MTC)?Mothercare plc ( LON:MTC ), is not the largest company out there, but it led the AIM gainers with a relatively large...
Reported Earnings • Nov 28First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.001 in 1H 2023)First half 2024 results: EPS: UK£0.003 (up from UK£0.001 in 1H 2023). Revenue: UK£29.0m (down 25% from 1H 2023). Net income: UK£1.70m (up 325% from 1H 2023). Profit margin: 5.9% (up from 1.0% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
New Risk • Nov 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.3x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (10.0% average weekly change). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (UK£29.9m market cap, or US$37.7m).
분석 기사 • Nov 04Mothercare plc (LON:MTC) Investors Are Less Pessimistic Than ExpectedWith a median price-to-sales (or "P/S") ratio of close to 0.3x in the Specialty Retail industry in the United Kingdom...
공시 • Sep 27Mothercare plc, Annual General Meeting, Oct 23, 2023Mothercare plc, Annual General Meeting, Oct 23, 2023, at 10:00 Coordinated Universal Time. Location: Westside 1, London Road Hemel Hemsptead United Kingdom Agenda: To receive the Company's annual accounts, together with the directors' report, the strategic report, the directors' remuneration report and the auditors' report for the 52 weeks ended 25 March 2023; to approve the directors' remuneration report for the 52 weeks ended 25 March 2023; to re-elect Clive Whiley as a director of the Company; to re-elect Andrew Cook as a director of the Company; to re-elect Gillian Kent as a director of the Company; to re-elect Mark Newton-Jones as a director of the Company; to re-elect Brian Small as a director of the Company and to consider other business matters.
Reported Earnings • Sep 24Full year 2023 earnings released: EPS: UK£0 (vs UK£0.021 in FY 2022)Full year 2023 results: EPS: UK£0 (down from UK£0.021 in FY 2022). Revenue: UK£73.1m (down 11% from FY 2022). Net loss: UK£100.0k (down 101% from profit in FY 2022). Revenue is forecast to stay flat during the next 3 years compared to a 5.9% growth forecast for the Specialty Retail industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.
분석 기사 • Aug 18We Like Mothercare's (LON:MTC) Returns And Here's How They're TrendingTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
New Risk • Jul 25New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings are forecast to decline by an average of 34% per year for the foreseeable future. Minor Risks High level of debt (883% net debt to equity). Market cap is less than US$100m (UK£34.2m market cap, or US$44.0m).
분석 기사 • Jun 11When Should You Buy Mothercare plc (LON:MTC)?Mothercare plc ( LON:MTC ), might not be a large cap stock, but it saw significant share price movement during recent...
공시 • Jun 09+ 1 more updateMothercare plc Daniel Le Vesconte to Step Down from His Role as Director of the BoardMothercare plc announces that Daniel Le Vesconte has stepped down from his role as Chief Executive Officer ("CEO") and as a Director of the Board with immediate effect. Clive Whiley, the Company's Chairman and Andrew Cook, the CFO, will revert to leading the Operating Board, as was the case for the previous three years, until the process to find a replacement CEO is completed.
분석 기사 • Mar 13Mothercare (LON:MTC) Is Very Good At Capital AllocationWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
Price Target Changed • Mar 12Price target decreased by 15% to UK£0.14Down from UK£0.17, the current price target is an average from 2 analysts. New target price is 63% above last closing price of UK£0.086. Stock is down 30% over the past year. The company is forecast to post earnings per share of UK£0.0015 for next year compared to UK£0.021 last year.
Board Change • Mar 12Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non Executive Director Brian Small was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 30First half 2021 earnings released: UK£0.038 loss per shareThe company reported a poor first half result with weaker earnings, revenues and control over expenses. First half 2021 results: Revenue: UK£44.4m (down 56% from 1H 2020). Net loss: UK£14.1m (down 352% from profit in 1H 2020). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings.
Reported Earnings • Sep 28Full year earnings released - UK£0.02 loss per shareOver the last 12 months the company has reported total losses of UK£7.20m, with losses narrowing by 67% from the prior year. Total revenue was UK£164.7m over the last 12 months, down 18% from the prior year.